Albemarle Corporation
NYSE:ALBChemicals - Specialty
-$6.21 today
- Market cap
- $10.13B
- Beta
- 1.31
- P/E (TTM)
- -81.1
- EPS (TTM)
- -$1.98
- Dividend yield
- 1.01%
Volume 2.16M
Average 2.29M
ALB EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
Albemarle CorporationNYSE: ALB
EPS (Basic) · Q2 FY2026 · quarter ended Jun 2026
EPS (Basic) turns positive
Q2 FY2026 EPS (Basic) was $3.72, compared with -$0.16 a year earlier. Trailing-twelve-month EPS (Basic) was $0.48.
Context
- EPS (Basic) increased in 1 of the last 3 fiscal years.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 10 analysts of $10.7 (+286.0%) for the fiscal year ending Dec 2026, a step up from the +48.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $3.72+58.3% QoQ
- Last fiscal yearDec 2025
- -$5.75+48.7% YoY
- LTMJun 2026
- $0.48+105.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +2425.0% | +247.1% | -2177.9 pp |
| 1 year | +48.7% | +286.0% | +237.4 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- (5.75) USD
- Year-over-year change
- +48.7%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (5.75) | +48.7% |
| FY2024 | 2024-12-31 | (11.20) | -183.5% |
| FY2023 | 2023-12-31 | 13.41 | -41.6% |
| FY2022 | 2022-12-31 | 22.97 | +2046.7% |
| FY2021 | 2021-12-31 | 1.07 | — |
EPS (Basic) vs competitors
How ALB compares with its peers on the latest reported figures
- ALB's LTM Jun 2026 EPS (Basic) of $0.48 is the 2nd highest of the 4 companies compared; the peer median is -$0.22.
- Its year-over-year change of +105.1% is the 2nd highest of 3, against a peer median of +45.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $4.86 | +191.0% | -46.8% | |
| LTM Jun 2026 | $0.48 | +105.1% | — | |
| LTM Mar 2026 | -$0.22 | — | — | |
| LTM Mar 2026 | -$0.46 | -99.5% | — | |
| Peer median (excluding ALB) | -$0.22 | +45.8% | -46.8% | |
Competitors are the stored peer set for ALB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.33B | 7.32B | 9.62B | 5.38B | 5.14B |
| Cost of Revenue | 2.32B | 4.23B | 8.42B | 5.32B | 4.47B |
| Gross Profit | 1.01B | 3.09B | 1.2B | 60.24M | 671.62M |
| Gross Margin | 30.3% | 42.2% | 12.5% | 1.1% | 13.1% |
| Research & Development | 54.03M | 71.98M | 85.73M | 86.72M | 51.4M |
| Selling, General & Admin | 421.79M | 512.15M | 874.16M | 609.53M | 526.43M |
| Operating Expenses | 475.81M | 584.13M | 959.89M | 696.25M | 577.83M |
| Depreciation & Amortization | 254M | 300.84M | 429.94M | 588.64M | 658.68M |
| EBITDA | 544.86M | 3.63B | 2.65B | (294.14M) | 558M |
| EBITDA Margin | 16.4% | 49.6% | 27.5% | -5.5% | 10.9% |
| Operating Income | 532.66M | 2.5B | 241.12M | (636.01M) | 93.79M |
| Operating Margin | 16.0% | 34.2% | 2.5% | -11.8% | 1.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 61.48M | 122.97M | 116.07M | 165.62M | 207.65M |
| Other Income / Expenses | (303.27M) | 704.26M | 1.86B | (412.39M) | (402.12M) |
| Income Before Tax | 229.39M | 3.21B | 2.1B | (1.05B) | (308.33M) |
| Pre-Tax Margin | 6.9% | 43.8% | 21.8% | -19.5% | -6.0% |
| Income Tax Expense | 29.45M | 390.59M | 430.28M | 87.09M | 156.88M |
| Net Income | 123.67M | 2.69B | 1.57B | (1.18B) | (510.63M) |
| Net Margin | 3.7% | 36.7% | 16.4% | -21.9% | -9.9% |
| EPS (Basic) | 1.07 | 22.97 | 13.41 | (11.20) | (5.75) |
| EPS (Diluted) | 1.06 | 22.84 | 13.36 | (11.20) | (5.75) |
| Weighted Avg Shares | 115.84M | 117.12M | 117.32M | 117.52M | 117.7M |
| Weighted Avg Shares (Diluted) | 116.54M | 117.79M | 117.77M | 117.52M | 117.7M |
Albemarle Corporation
NYSE:ALB
Intrinsic Alpha fair value
Locked
Current Price
$85.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.